TCM Biotech International Corp. - Laporan Laba Rugi (TTM)

TCM Biotech International Corp.
TW ˙ TPEX
Laporan Laba Rugi (TTM)

Laporan Laba Rugi TCM Biotech International Corp. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 719 737 712 686 694 702 711 720 761 802 849 895 932 970 902 834 750 667 670 674
Change (%) 2.55 -3.44 -3.56 1.14 1.12 1.30 1.29 5.70 5.39 5.75 5.44 4.19 4.02 -6.98 -7.50 -10.06 -11.18 0.59 0.59
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 360 368 358 348 346 343 333 323 339 354 389 425 457 489 456 423 381 339 346 353
Change (%) 2.34 -2.76 -2.83 -0.65 -0.66 -2.89 -2.98 4.71 4.50 10.00 9.09 7.62 7.08 -6.80 -7.30 -9.89 -10.98 2.01 1.97
% of Revenue 50.05 49.95 50.30 50.68 49.78 48.90 46.88 44.91 44.49 44.11 45.88 47.47 49.03 50.48 50.57 50.68 50.78 50.89 51.61 52.32
Gross Operating Profit 359 369 354 339 349 359 378 397 423 448 459 470 475 480 446 411 369 327 324 322
Change (%) 2.76 -4.11 -4.29 2.97 2.89 5.32 5.05 6.50 6.10 2.40 2.34 1.08 1.07 -7.16 -7.71 -10.22 -11.39 -0.88 -0.89
% of Revenue 49.95 50.05 49.70 49.32 50.22 51.10 53.12 55.09 55.51 55.89 54.12 52.53 50.97 49.52 49.43 49.32 49.22 49.11 48.39 47.68
SG&A 250 260 262 264 270 276 288 300 321 341 358 374 377 380 341 302 263 223 218 213
Change (%) 4.18 0.71 0.70 2.29 2.24 4.41 4.22 6.80 6.37 4.78 4.56 0.85 0.84 -10.33 -11.52 -12.99 -14.93 -2.42 -2.48
% of Revenue 34.77 35.32 36.84 38.46 38.90 39.33 40.54 41.71 42.15 42.54 42.15 41.80 40.46 39.23 37.82 36.17 34.99 33.52 32.51 31.52
R&D 61 72 79 86 83 80 79 77 79 82 80 77 77 77 80 83 88 93 94 94
Change (%) 17.59 10.23 9.28 -3.32 -3.43 -2.10 -2.14 3.06 2.97 -2.66 -2.73 0.01 0.01 3.74 3.60 5.98 5.65 0.64 0.63
% of Revenue 8.46 9.70 11.08 12.55 12.00 11.46 11.07 10.70 10.43 10.19 9.38 8.66 8.31 7.99 8.91 9.98 11.76 13.99 13.99 14.00
OpEx 670 700 699 698 699 700 700 701 739 777 827 876 912 947 878 808 732 656 658 660
Change (%) 4.41 -0.14 -0.14 0.13 0.13 0.08 0.08 5.43 5.15 6.37 5.99 4.06 3.90 -7.36 -7.94 -9.41 -10.39 0.31 0.31
% of Revenue 93.28 94.97 98.21 101.69 100.68 99.70 98.49 97.32 97.07 96.85 97.42 97.93 97.81 97.70 97.30 96.84 97.53 98.40 98.12 97.84
Operating Income 48 37 13 -12 -5 2 11 19 22 25 22 19 20 22 24 26 19 11 13 15
Change (%) -23.28 -65.67 -191.25 -59.18 -144.97 403.00 80.12 15.53 13.44 -13.37 -15.44 10.23 9.28 9.10 8.34 -29.74 -42.33 18.07 15.30
% of Revenue 6.72 5.03 1.79 -1.69 -0.68 0.30 1.51 2.68 2.93 3.15 2.58 2.07 2.19 2.30 2.70 3.16 2.47 1.60 1.88 2.16
Interest Expense -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -3 -3 -3 -3 -3 -2 -2 -2 -1 -1
Change (%) -4.39 -3.62 -3.76 4.57 4.37 3.88 3.74 6.14 5.79 8.53 7.86 -0.36 -0.36 -9.11 -10.02 -14.58 -17.07 -16.87 -20.30
% of Revenue -0.28 -0.26 -0.26 -0.26 -0.27 -0.28 -0.29 -0.29 -0.30 -0.30 -0.31 -0.31 -0.30 -0.29 -0.28 -0.27 -0.26 -0.24 -0.20 -0.16
Net Income 34 26 10 -5 -2 2 5 8 13 18 16 13 16 19 19 20 21 21 24 27
Change (%) -23.94 -60.31 -151.97 -67.78 -210.34 169.78 62.93 60.93 37.86 -13.25 -15.28 19.19 16.10 3.85 3.70 2.52 2.46 14.28 12.49
% of Revenue 4.67 3.47 1.42 -0.77 -0.24 0.27 0.71 1.14 1.74 2.28 1.87 1.50 1.72 1.92 2.14 2.40 2.73 3.15 3.58 4.00

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista